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Retinyl esterHepatic stellate cells (HSCs) store triglycerides (TGs) and retinyl ester (RE) in cytosolic lipid droplets. RE stores
are degraded following retinoid starvation or in response to pathogenic stimuli resulting in HSC activation.
At present, the major enzymes catalyzing lipid degradation in HSCs are unknown. In this study, we investigated
whether adipose triglyceride lipase (ATGL) is involved in RE catabolism of HSCs. Additionally, we compared the
effects of ATGL deﬁciency and hormone-sensitive lipase (HSL) deﬁciency, a known RE hydrolase (REH), on RE
stores in liver and adipose tissue. We show that ATGL degrades RE even in the presence of TGs, implicating
that these substrates compete for ATGL binding. REH activity was stimulated and inhibited by comparative
gene identiﬁcation-58 and G0/G1 switch gene-2, respectively, the physiological regulators of ATGL activity.
In cultured primary murine HSCs, pharmacological inhibition of ATGL, but not HSL, increased RE accumulation.
In mice globally lacking ATGL or HSL, RE contents in white adipose tissue were decreased or increased, respec-
tively, while plasma retinol and liver RE levels remained unchanged. In conclusion, our study shows that ATGL
acts as REH in HSCs promoting the degradation of RE stores in addition to its established function as TG lipase.
HSL is the predominant REH in adipocytes but does not affect lipid mobilization in HSCs.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Retinoids (vitamin A) are fat-soluble micronutrients with numerous
important functions, including a role in vision, reproduction, immunity,
and the development and maintenance of differentiated tissues [1].
Dietary retinol (ROH) is esteriﬁed with long-chain fatty acids (FAs),
preferentially palmitic acid (PA), and stored in form of retinyl ester
(RE). Although most tissues of the body contain trace amounts of RE,
they are predominantly (up to 80%) stored in the liver where they are
deposited in lipid droplets (LDs) of hepatic stellate cells (HSCs) [2].
Healthy individuals contain vitamin A reserves sufﬁcient for an ade-
quate supply of the body for up to several months. In times of insufﬁ-
cient vitamin A uptake, RE stores are mobilized to ensure a constant
concentration of ~1 μMROH in the circulationwhich is essential for nor-
mal body function [3]. In the circulation, ROH is attached to retinol-
binding protein 4 (RBP4) and is transported to target tissues where itiosciences, University of Graz,
1900; fax: +43 316 380 9016.
ert.zimmermann@uni-graz.at
. This is an open access article undercan be re-esteriﬁed or converted into its bioactive metabolites, which
possess essential roles in vision and gene regulation. 11-cis
retinaldehyde functions as the active chromophore in rhodopsin.
All-trans and 9-cis retinoic acid interact with a number of nuclear
receptors of the retinoic acid receptor (RAR) and the retinoid X
receptor (RXR) family. These receptors function as ligand-activated
transcription factors and regulate the expression of numerous
genes [4,5].
The availability of ROH fromendogenous stores is determined by the
synthesis and hydrolysis of RE. InHSCs, ROH is esteriﬁed by the action of
lecithin:retinol acyltransferase (LRAT). LRAT-deﬁcient mice possess
only trace amounts of RE in HSCs and are more susceptible to develop
retinoid deﬁciency [6], demonstrating that this enzyme is required
for efﬁcient RE storage. Yet these mice exhibit elevated RE levels in
white adipose tissue (WAT) and are capable of esterifying ROH
in other tissues in an acyl-CoA-dependent reaction. Presumably, this
reaction [acyl-CoA:retinol acyltransferase activity] is mediated by acyl-
CoA:diacylglycerol acyltransferase 1, an enzyme with broad substrate
speciﬁcity catalyzing the synthesis of triglycerides (TGs), diglycerides
(DGs), and waxes [7]. The mobilization of ROH from RE stores requires
the activity of enzymes possessing RE hydrolase (REH) activity. To
date, very little is known about lipases involved in RE mobilization inthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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[7,8]. Yet it is reasonable to assume that REmobilization is a tightly reg-
ulated process, since the liver is capable of keeping constant plasma
ROH levels despite strong variations in dietary retinoid uptake.
Although a number of enzymes have been reported to hydrolyze RE
in vitro [7], hormone-sensitive lipase (HSL) and retinal pigment epithe-
lium 65 (RPE65) are the only known enzymes, which have been shown
to affect retinoid metabolism in vivo [9,10]. However, HSL is hardly
detectable in HSCs [11], and RPE65 is speciﬁcally expressed in retinal
pigment epithelium, a specialized cell type controlling retinoidmetabo-
lism in the eye [12]. In the search for enzymes involved in HSCs lipid
catabolism, we found that adipose triglyceride lipase [ATGL [13], identi-
cal to desnutrin and patatin-like phospholipase domain containing 2
(PNPLA2)] can hydrolyze RE in the presence of its co-activator compar-
ative gene identiﬁcation-58 [CGI-58, identical toα/β-hydrolase domain
containing-5 [14]]. Our ﬁndings indicate that ATGL functions as REH in
HSCs in addition to its established role in TG catabolism.
2. Materials and methods
2.1. Materials
All-trans-retinol (ROH), retinyl acetate (RAc), retinyl palmitate (RP),
and fatty acid (FA)-free BSA were from Sigma-Aldrich (Taufkirchen,
Germany).
2.2. Animals
Micewere maintained on a regular light–dark cycle (12 h light, 12 h
dark) and kept ad libitum on a standard laboratory chow diet (Ssniff
Spezialdiaeten, Soest, Germany, Vitamin A ~15,000 IU/kg) or on a
Vitamin A-deﬁcient diet (Ssniff, Vitamin A b 120 IU/kg). ATGL-ko and
HSL-ko mice were generated by targeted homologous recombination
as described previously [15,16]. Animals were 8–12 weeks of age.
Female mice were used for all studies. Non-fasted animals were anes-
thetized with IsoFlo/Isoﬂurane (Abbott, Animal Health, Queenborough,
Kent, UK) and euthanized by cervical dislocation. The study was
approved by the ethics committee of the University of Graz and is in
accordance with the Council of Europe Convention (ETS 123).
2.3. cDNA cloning of recombinant tagged proteins
The open reading frames (ORF) of murine PNPLA1, ATGL, and
adiponutrin were cloned into pcDNA4™/HisMaxC (Invitrogen; Life
Technologies, Carlsbad, USA), as described previously [17,18], and
transfected into COS-7 cells (ATCC CRL-1651) using Metafectene
(Biontex GmbH, Munich, Germany). PNPLA1 was cloned using the
following primers: fw-5′-AAGAATTCGAACAGGTGTTCAAAGGAG-3′ and
rev-5′-AACTCGAGTTAGGAGTTCTGGCCACTCACT-3′: for the expression
of murine ATGL and CGI-58 in Escherichia coli, sequences encoding the
ORF of ATGL and CGI-58 were inserted into the target vector pASK-
IBA5plus (IBA, Goettingen, Germany) and transformed into E. coli as
described [17].
2.4. Immunoblotting
Proteins of cell lysates or tissue homogenates were separated
by SDS–PAGE according to their molecular weight using Tris/glycine
as electrophoresis buffer andwere transferred onto polyvinylideneﬂuo-
ride membranes (Carl Roth GmbH, Karlsruhe, Germany) using CAPS
buffer. After blocking, membranes were hybridized with respective
primary antibodies. Membranes were washed, incubated with respec-
tive secondary horseradish-peroxidase (HRP)-conjugated antibody
and detected using ECL2Western blotting substrate (Thermo Scientiﬁc,
Waltham, MA). Antibodies used were rabbit anti-HSL, rabbit anti-
phospho-HSL (S660), and rabbit anti-GAPDH (all from Cell Signaling,Danvers, MA, USA), rabbit anti-CGI-58 (Abnova, Heidelberg), mouse
anti-β-Actin (Santa Cruz, Santa Cruz, CA, USA), rabbit anti-alpha smooth
muscle actin (α-SMA, Pierce, Thermo Scientiﬁc), HRP-linked sheep-anti
mouse antibody (GE Healthcare Amersham, Buckinghamshire, UK), and
HRP-linked rat-anti rabbit antibody (Dako, Glostrup, Denmark).
2.5. Isolation of HSCs
HSCs were isolated according to the method of Blomhoff et al. [19]
with some modiﬁcations. Brieﬂy, livers of anaesthetized mice were
perfused via the portal vein using Krebs–Henseleit buffer (KHB, without
Ca2+ and SO42−) followed by perfusionwith KHB containing 0.15mg/ml
collagenase type II (Worthington Biochemical Corporation, Lakewood,
NJ), 0.1 mg/ml Pronase E (Merck, Darmstadt, Germany), 2% BSA,
and 0.1 mM CaCl2. Thereafter, livers were excised, disrupted, passed
through a metal sieve, and ﬁltered through a 70 μm nylon cell strainer
(BD Biosciences, San Jose, CA). Parenchymal cells were separated from
non-parenchymal cells (NPCs) by centrifugation (50 ×g, 3 min, 4 °C).
The supernatant was used for the isolation of HSCs using OptiPrep™
self-forming density gradient solutions (Axis-Shield PoC AS, Rodeløkka,
Norway) as described previously [20]. After centrifugation, HSCs were
collected, washed with PBS, and used for Western blotting analyses.
For cell culture experiments, total NPCs were seeded into cell culture
dishes in Dulbecco's modiﬁed Eagle medium (DMEM) containing 20%
fetal calf serum (FCS), 100 μg/ml primocin, and antibiotics. After
2 days in culture, cells were trypsinized and seeded again [selective
detachment according to Trøen et al. [21]]. After 10 days in culture,
~90% of cells stained positive forα-smoothmuscle actin (α-SMA), indi-
cating the presence of activated stellate cells. A representative stain for
α-SMA is shown in Fig. S1.
2.6. Lipid accumulation in primary HSCs
HSCs were seeded into 6-well plates and cultured for 10 days in
DMEM media containing 20% FCS, 100 μg/ml primocin, and antibiotics.
ROH (5 μM) was added to the medium to prevent complete loss of RE
stores [21]. Cells were loaded for 24 h with 20 μM ROH and 50 μM
palmitic acid (PA) complexed to BSA. Thereafter, cells were starved in
DMEMmedia containing 2% FA-free BSA. At indicated time points, lipids
were extracted with hexane:isopropanol (3:2; 0.5 mM butylated hy-
droxytoluene (BHT)).
2.7. Analysis of tissue and plasma ROH and RE by HPLC
Retinoids of liver, WAT, and plasma samples were extracted with
ice-cold hexane:methanol:PBS (5:1:1; 0.5 mM BHT and 100pmol RAc/
sample as internal standard). Hexane phase was dried, and lipids were
dissolved in methanol and subjected to HPLC analysis. Retinoids were
separated on a reverse phase pro-C18 column (250 × 4.6 mm; 12 nm,
S-5 μm; YMC Europe, Dinslaken, Germany) using a gradient of metha-
nol:toluene at a ﬂow rate of 1.0 ml/min. The HPLC system consisted of
Waters e2695 Separation Module, UV/VIS 2489 Detector, and a Multi-
λ Fluorescence 2475 Detector (Waters, Millford, MA). For the detection
of ROH and RE, excitation was set at 325 nm and emission at 490 nm.
ROH eluted at a retention time of 5.3 min, whereas RE eluted as a single
peak at a retention time of 12.2 min. ROH and RE were quantiﬁed by
comparison with the internal standard.
2.8. Determination of enzyme activities
The determination of TG hydrolase activities was performed using
[9,10-3H]-triolein (TO) (PerkinElmer Life Sciences) as radioactive tracer
as described [22]. The substrate for the determination of REH activities
consisted of RP and phosphatidylcholine (molar ratio 1:0.9) in 0.1 M
potassium phosphate buffer (pH 7.0). Substrate was prepared by soni-
cation (Virsonic 475, Virtis, Gardiner, NJ) on ice and adjusted to 5% FA-
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total protein) were incubated with 100 μl lipid substrate at 37 °C for
1 h in a shaking water bath. In some cases puriﬁed G0S2 [23] was
added to the incubation mixture. The reaction was terminated by the
addition of ice-cold methanol (containing 0.5 mM BHT and 100pmol
RAc/sample as internal standard) and hexane. Retinoidswere extracted,
and the hexane phasewas dried. The release of ROHwas determined by
HPLC.2.9. Determination of TG and RE content of HSCs
Cells were washed with PBS, then cellular lipids were extracted
with hexane:isopropanol (3:2), and the hexane phase was dried and
dissolved in methanol for the determination of RE content (see
above). For TG measurement, lipids were dissolved in chloroform (con-
taining 1% Triton X-100), and the solvent was evaporated again. Lipids
were solubilized in deionized water by vigorous shaking, and TG
content was determined using a commercial Kit (InﬁnityTM triglycer-
ides, Thermo Scientiﬁc).3. Immunohistochemistry of HSC
Cells were seeded at a density of 1 × 105/cm2 onto Lab-Tek chamber
slights (Thermo Scientiﬁc) and cultured overnight in DMEM (4.5mg/ml
glucose, 20% FCS and100 μg/ml primocin). After 24 h, cellswerewashed
with PBS and ﬁxed with ice-cold methanol-acetone (1:1) for 10 min at
−20 °C. The solution was carefully removed, and cells were washed
again with PBS. HSCs were identiﬁed by staining with monoclonal anti
α-SMA. Brieﬂy, cells were incubated with monoclonal α-SMA antibody
for 1 h at room temperature (RT). Slides were washed with PBS follow-
ed by 30 min incubation with the secondary antibody anti-mouse FITC
(ﬂuorescein isothiocyanate). After washing with ddH2O and ethanol,
slides were dried in the dark and mounted with Moviol (Hoechst,
Frankfurt, Germany). Slides were immediately subjected to microscopy
(Zeiss LSM 510, Oberkochen, Germany) and FITC-ﬂuorescence was de-
tected at 488 nm.3.1. Microscopy
Coherent anti-Stokes Raman scattering (CARS) microscopy of
primary HSCs was performed using a commercial setup consisting of
a picosecond laser source and an optical parametric oscillator
(picoEmerald; APE, Germany; HighQ Laser, Austria) integrated into a
Leica SP5 confocal microscope (Leica Microsystems, Inc.). The detection
of the CARS signal was achieved using 650/210 and 770/SP emission ﬁl-
ters. The microscope was equipped with a non-descanned detector for
acquisition of signals in forward (F-) CARS mode. To detect neutral
lipids, the laser was tuned to 2845 cm−1, thus enabling imaging of
CH2 symmetric stretching vibrations. For imaging a Leica 1.25 NA,
40 × oil objective was used.3.2. Protein determination
Protein concentrations were determined by Bio-Rad protein (Bio-
Rad) or BCA protein assay (Thermo Scientiﬁc) kits according to
manufacturer's instructions using BSA as standard.3.3. Statistical analyses
Values are means ± standard deviation (SD). Statistical signiﬁcance
was determined by Student's unpaired t-test (two-tailed). Group differ-
ences were considered statistically signiﬁcant for *p b 0.05, **p b 0.01,
and ***p b 0.001.4. Results
4.1. ATGL hydrolyzes RE in vitro
Recent evidence suggests that human adiponutrin (PNPLA3) is able
to hydrolyze RE in vitro [24]. Thus, we investigated whether mouse
PNPLA3 and the closest mouse homologues, PNPLA1 and ATGL
(PNPLA2), are capable of hydrolyzing RE. REH activity assays were
performed using lysates of COS-7 cells expressing murine PNPLA1,
ATGL, and adiponutrin. We did not detect REH activity for any of these
enzymes. However, the addition of CGI-58, the co-activator protein of
ATGL, to the cell lysates increased REH activity 1.5-fold in ATGL contain-
ing lysates. No activation was observed for PNPLA1 and adiponutrin
(Fig. 1A). To conﬁrm REH activity of ATGL, we expressed ATGL in
E. coli and determined REH activities in these lysates in the absence or
presence of CGI-58 and the ATGL-speciﬁc inhibitory protein G0/G1
switch gene 2 (G0S2) [25]. The expression of ATGL-elevated REH activ-
ity in bacterial lysates and the addition of CGI-58 further increased this
activity by 2.7-fold. Conversely, G0S2 completely abolished ATGL's REH
activity (Fig. 1B). Further experiments revealed that ATGL degrades RE
in a time- and dose-dependent manner (Fig. 1C, D).
RE and TGs are present at similar concentrations in LDs of HSCs [2,
26–28]. To investigate whether ATGL is capable of degrading RE in the
presence of TG and vice versa, we preparedmixed substrates containing
equimolar concentrations of TO and RP and incubated themwith lysates
containing ATGL and CGI-58. The addition of TO to the RP substrate
reduced ATGL's REH activity by ~50% (Fig. 1E). Notably, TG hydrolase
activity of ATGL was also reduced by ~ 60% in the presence of RP
suggesting that these substrates compete for ATGL binding (Fig. 1F).
To investigate whether ATGL-ko mice exhibit reduced neutral REH
activity in liver, we measured REH activity in lipid-poor lysates
(20.000 ×g infranatant) prepared from total liver, from isolated hepato-
cytes, or from isolated non-parenchymal cells (NPCs). In comparison to
the wild-type controls, REH activities in total liver, hepatocytes, and
NPCs of ATGL-komicewere decreased by 27%, 26%, and 44%, respective-
ly (Fig. 1G). These observations indicate that ATGL contributes to the
neutral REH activity detected in liver preparations, but is clearly not
the only enzyme capable of catalyzing this reaction.
4.2. ATGL is expressed in HSCs and affects cellular RE and TG contents
ATGL protein expression was detected in HSCs (Fig. 2A, lane III) but
remained below detection limit in the hepatocyte or total NPC fraction
(Fig. 2A, lane I and II, respectively). HSL is a major REH in WAT but
only poorly expressed in the liver [11]. We could not detect HSL protein
expression in HSCs (Fig. 2A, lane III), whereas HSL was detected in the
hepatocyte and total NPC fraction (Fig. 2A, lane I and II, respectively).
To investigate whether inhibition of ATGL and/or HSL affects RE catabo-
lism in cultured wild-type HSCs, we inhibited respective lipases with
ATGL and/or HSL speciﬁc inhibitors, Atglistatin (Ai) [29] and/or Hi-76-
0079 (Hi) [30], respectively. After incubation of primary HSCs for 12 h
in the presence of 5 μM ROH, Ai caused a 30% increase of cellular RE
content, while inhibition of HSL did not change RE levels (Fig. 2B).
These observations indicate that ATGL, but not HSL, contributes to RE
mobilization in HSCs. In accordance with our observation, previous
studies reported high ATGL mRNA levels in HSCs [11,31]. When we
cultured primary HSCs for 7 days in the presence of Ai, we determined
a 1.7-fold increase in RE content and a 14-fold increase in TG content
(Fig. 2C, D). This treatment did not affect the expression of α-SMA
(Fig. 2E), suggesting that the lack of ATGL activity does not inﬂuence
HSC activation. CARS microscopy analysis of HSCs isolated from wild-
type and ATGL-ko mice, allowing the label-free detection of lipid stores,
revealed larger LDs in HSCs lacking ATGL (Fig. 2H). RE and TG contents
of ATGL-koHSCswere increased 2.4-fold (Fig. 2F) and 6.7-fold (Fig. 2G),
respectively, in comparison to wild-type HSCs. Furthermore, a time
course experiment revealed that isolated wild-type HSCs lost 50% of
Fig. 1.ATGL exhibits REH activity. (A) REH activities were determined in COS-7 cell lysates containing PNPLA1, ATGL, or adiponutrin as well as upon the addition of lysates containing CGI-
58. Lysates containing LacZwere used as negative control. Insert shows the expression of respective enzymes byWestern blotting analysis. Coomassie blue (CB) stain was used as loading
control. (B) REH activities of E. coli lysates containing ATGL, CGI-58, or of empty vector transformed cells (EV) were determined in the presence or absence of puriﬁed G0S2. REH activities
(release of ROH) of bacterial lysates containing ATGL and CGI-58 were determined at different time points (C), and with increasing protein concentrations (D) using RP emulsiﬁed with
phospholipids (PL) as substrate. Insert in C shows theexpression of ATGL andCGI-58 in E. colibyWestern blotting analysis. (E) REHactivities of E. coli lysates containing ATGL andCGI-58or
of EV transformed cells were determined using RP or an equimolarmixture of RP and triolein (TO) emulsiﬁedwith PL as substrates. (F) As in E but using TO or an equimolarmixture of TO
and RP emulsiﬁed with PL as substrates. (G) REH activities were determined in liver lysates and cell lysates of primary hepatocytes and non-parenchymal cells (NPCs) of wild-type and
ATGL-ko mice using RP emulsiﬁed with PL as substrate. ROH release was determined by HPLC (n= 5–7/genotype). All data are representative for at least two independent experiments
performed in triplicates and are presented as means ± SD (*p b 0.05; **p b 0.01; ***p b 0.001).
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their initial stores after 24 h (Fig. 2I). Thus, ATGL deﬁciency substantially
attenuates RE mobilization in HSCs.
4.3. ATGL- and HSL-deﬁcient mice exhibit unchanged liver and plasma ROH
and RE levels but decreased and increased RE stores in adipose tissue,
respectively
In order to investigate whether the lack of ATGL or HSL affect RE
metabolism in vivo, we compared plasma, hepatic, and adipose tissue
ROH and RE levels of wild-type and ATGL-ko mice. To exclude the
contribution of dietary vitamin A, mice were fed a retinoid-deﬁcient
diet for 3 weeks. As shown in Fig. 3A, circulating ROH concentrations
did not differ between groups and we did not observe differences in
hepatic RE content between wild-type and ATGL-ko mice (Fig. 3B).
Interestingly, however, WAT RE stores of ATGL-ko mice were depleted
as compared to wild-type mice (Fig. 3C). We also could not observe
any differences in circulating ROH levels or hepatic RE stores in HSL-
ko mice (Fig. 3D, E). In accordance with published data [9], these mice
showed an 8-fold increase in WAT RE content (Fig. 3F), implicating a
central role of HSL in WAT RE catabolism. Furthermore, hepatic ROH
levels were not different between wild-type and ATGL-ko or HSL-ko
mice (Fig. S2). Notably, we found increased HSL phosphorylation in
ATGL-ko WAT (Fig. 3G), indicative for increased HSL activity which
may explain the depletion of WAT RE stores in ATGL-ko mice.
5. Discussion
ATGL deﬁciency leads to impaired lipolysis in many tissues, and is
associated with systemic TG accumulation in rodents and humans
[32]. Several studies demonstrated that ATGL is also a key TG lipase in
hepatocytes [33,34]. Moreover, the enzyme is expressed in hepatic
and non-hepatic resident cell types such as quiescent and activated
HSCs, Kupffer cells, and macrophages [11,35]. Here we demonstrate
that cultured mouse HSCs lacking ATGL exhibit a substantial increase
in TG storage conﬁrming an important role of the enzyme in this cell
type. We originally reported that ATGL catalyzes speciﬁcally the hydro-
lysis of TG into DG and FA and has no detectable REH activity [13].
However, these observations were made prior to the discovery of CGI-
58, the activator protein of ATGL [14]. Present data demonstrate that
ATGL possesses REH activity that is stimulated by CGI-58 and inhibited
by G0S2, the physiological activator and inhibitor proteins of ATGL.
Although ATGL degrades TGs at amuch higher rate than RE, REH activity
was clearly detected in the presence of equimolar concentrations of TG.
Notably, the addition of RE to the substrate inhibited TGhydrolase activ-
ity of ATGL, suggesting that RE and TGs compete for ATGL binding.
Moriwaki et al. [28] reported the lipid composition of lipid droplets iso-
lated from primary rat HSCs as follows: 39.5% RE, 31.7% TG, 15.4%
cholesteryl ester, 6.3% phospholipid, 4.7% cholesterol, and 2.4% FFAs.
Based on our in vitro substrate competition assays, this lipid droplet
composition enables ATGL to hydrolyze both RE and TGs.
The lack of ATGL in cultured primary HSCs attenuates RE and TG
degradation in vitro. This observation provides new insights into the
molecular mechanisms of lipolysis in HSCs. It will be highly interesting
to examine whether RE degradation in these cells is activated or
inactivated byhormonal signals known to control lipolysis in adipocytes
[36]. However, ATGL is clearly not the only enzyme involved in RE
hydrolysis. ATGL deﬁciency in mice neither caused RE accumulation in
the liver nor affected circulating ROH levels, suggesting a redundant
enzyme system catalyzing RE degradation in HSCs. Published data indi-
cate that RPE65, HSL, and human PNPLA3, as well as a number of other
enzymes, including bile-salt activated carboxylester lipase, rat
carboxylesterases 2, 3, 4, and 10 [8], are capable of hydrolyzing RE
in vitro. Recently, we reported that mouse esterase 22 (Es22, the
orthologue of rat carboxylesterase 3) is a potent REH, which is highly
expressed in hepatocytes and not present in HSCs. Es22 is located atthe ER, implicating that it rather counteracts RE formation at the ER
than mobilizing cytosolic RE depots [20]. Interestingly, a patatin-
domain containing protein named GS2 (gene sequence 2, annotated
as PNPLA4), which exhibits homology to ATGL, was also shown to
possess REH activity [37]. GS2 was originally identiﬁed as transacylase
and lipase in keratinocytes. The human enzymewas reported to hydro-
lyze RE and TGs as well as to catalyze acyl-CoA-dependent and acyl-
CoA-independent ROH esteriﬁcation. GS2 is not encoded by the mouse
genome, and the rat orthologue of the human enzyme does not share
these activities [38]. Thus, it is reasonable to assume that, in addition
to ATGL, one or more of these RE-degrading enzymes are involved in
retinoid metabolism in HSCs. Yet their role in retinoid metabolism
in vivo remains to be investigated. Furthermore, RE storage in HSCs is
strongly dependent on LRAT activity [39]. To date, it is unclear if de-
creased RE synthesis (e.g. decreased LRAT activity) in ATGL-deﬁcient
HSCs counteracts RE accumulation, and that is why these animals do
not exhibit increased liver RE content.
WAT contains the second largest RE depot of the body [40]. Interest-
ingly, we observed depletion of WAT RE stores in ATGL-ko animals.
WAT expresses HSL, which acts as major REH in adipocytes [9] and is
the rate-limiting enzyme in the degradation of DGs [15,41]. Several
studies demonstrate that HSL deﬁciency is associated with loss of
WAT and reduced activity of peroxisomeproliferator-activated receptor
(PPAR)-γ, a crucial adipogenic transcription factor [42–44]. Ström et al.
[9] proposed that defective ROH mobilization in HSL-ko adipocytes
might be responsible for the lean phenotype and for the down-
regulation of PPARγ target genes in HSL-ko mice since changes in
retinoid levels can affect adipocyte survival and the activation of
PPARγ/RXR heterodimers. In accordance with this report, we detected
RE accumulation in WAT of HSL-ko mice conﬁrming its important role
in RE degradation in adipocytes. However, HSL is not expressed in
HSCs, and we could not observe an increase in HSC RE content in
response to pharmacological HSL inhibition. These observations impli-
cate that HSL does not play a role in lipid catabolism of HSCs.
It is important to note that ATGL deﬁciency inmice is also associated
with a down-regulation of PPARα- and PPARδ-target genes in tissues
with high energy consumption [45,46]. Since PPARs have a prominent
role in the transcriptional regulation of genes involved in FA uptake
and oxidation, ATGL deﬁciency is associated with impaired mitochon-
drial respiration.Mechanistically, it has been proposed that ATGL gener-
ates long-chain FAs which could directly serve as ligands for PPARs or
are required for the synthesis of ligands. In addition, the activation of
PPARs is dependent on the formation of a heterodimer with RXR,
which requires retinoic acid as ligand. Thus, ATGL could inﬂuence
PPAR activity by increasing the cellular concentration of both FAs and
ROH. It is also interesting to note that G0S2, the physiological inhibitor
of ATGL, was identiﬁed as retinoic acid target gene and therefore
might be involved in the regulation of cellular retinoid levels via inhibi-
tion of ATGL activity.
The lipolytic process in HSCs clearly has pathophysiological
relevance since HSCs transform into a myoﬁbroblast-like cell type in
response to pathogenic signals. These activated cells are characterized
by the loss of lipid stores and high expression of α-SMA. Activated
HSCs start proliferating and are centrally involved in the synthesis and
remodeling of the extracellular matrix in ﬁbrosis [47]. It is believed
that a treatment leading to the reduction of the ﬁbrogenic or prolifera-
tive characteristics of HSCs can counteract the progression of liver
disease [48]. Several studies have addressed the question how vitamin
A inﬂuences liver ﬁbrosis and HSC activation [49]. These studies are
difﬁcult to interpret since retinoids prevented or promoted liver
disease, depending on the model system and on the experimental
conditions. On the one hand, retinoids repress activation of HSCs
[50–52], and vitamin A deﬁciency potentiates carbon tetrachloride-
induced liver ﬁbrosis in rats [53], suggesting a protective role of hepatic
retinoid stores. On the other hand, the absence of RE stores in LRAT-ko
mice does not promote ﬁbrosis but appears to protect the chronically
Fig. 2. ATGL is expressed in HSCs and affects cellular RE and TG stores. (A)Western blotting analysis of cell lysates of mouse primary hepatocytes (I), total NPCs (II), and isolated HSCs (III)
showing the expression of ATGL, HSL, and α-SMA. Coomassie blue (CB) stain was used as loading control. (B) Primary HSCs were isolated and cultured for 10 days in DMEM containing
5 μMROH. Then cells weremaintained in the presence of DMSO (control), 40 μMAtglistatin (Ai), 20 μMHi-76-0079 (Hi), or the combination thereof. After 12 h, lipidswere extracted, and
the cellular RE content was determined by HPLC. (C, D) Primary HSCs were isolated and cultured for 10 days in the absence or presence of Ai (daily, 40 μM). Lipidswere extracted and the
cellular RE content was determined by HPLC (C). Cellular TG content was determined using a commercial kit (D). (E) Expression ofα-SMAwas determined byWestern blotting analysis,
GAPDH and CB stain were used as loading control. (F, G) RE and TG contents of HSCs fromwild-type and ATGL-ko mice cultured in DMEM containing 20% FCS and 5 μMROH for 10 days.
RE and TG contentswere determined as in (C, D). (H) CARSmicroscopy analyses of culturedHSCs derived fromwild-type andATGL-komice. (I) PrimaryHSCs fromwild-type and ATGL-ko
mice were loaded for 24 hwith 20 μMROH and 50 μMPA. Then cells were starved in serum-free DMEM containing 2% BSA. At indicated time points, lipidswere extracted, and the cellular
RE content was determined by HPLC. Data are representative for at least two independent experiments and are presented as means ± SD (*p b 0.05;**p b 0.01; ***p b 0.001).
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retinoids can cause liver damage [54], and it has been suggested
that the rapid loss of retinoid stores can lead to toxic concentrations ofbioactive retinoids, thereby promoting cell death and disease develop-
ment [49,55]. Our studies suggest that a 7-day treatment of HSCs with
ATGL inhibitor does not affect the expression of myoﬁbroblast marker
Fig. 3. Plasma, liver, andWATROHandRE concentrations ofwild-type andmutantmice.Wild-type, ATGL-ko, andHSL-komicewere fed a retinoid-free diet for 3weeks. Then animalswere
sacriﬁced and plasma ROH (A, D), liver RE (B, E), and WAT RE (C, F) contents were determined by HPLC (n = 5–7/genotype). (G) HSL phosphorylation was determined in 1,000 ×g
supernatant of wild-type and ATGL-ko WAT. Expression of β-actin was used as loading control. Insert depicts densitometric quantitation of HSL phosphorylation as normalized to β-
actin. Data are presented as means ± SD (**p b 0.01; ***p b 0.001).
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ATGL deﬁciency affects theﬁbrogenic and proliferative characteristics of
HSCs in vivo. Published data suggest a protective role of ATGL against
steatosis and hepatic inﬂammation [56].
In conclusion, our study provides novel insights into the molecular
mechanisms regulating retinoid homeostasis. In addition to its
established function as TG lipase, ATGL acts as REH in HSCs promoting
the degradation of RE stores. HSL is the predominant REH in adipocytes
but does not affect lipid mobilization in HSCs.
Abbreviations
α-SMA α-smooth muscle actin
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PPAR peroxisome proliferator-activated receptor
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RAR retinoic acid receptor
RE retinyl ester
REH retinyl ester hydrolase
ROH retinol
RP retinyl palmitate
RPE65 retinal pigment epithelium 65
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